- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pterygium of the Conjunctiva and Cornea in Russian Federation
Total 216 results
-
Novartis PharmaceuticalsCompletedMyasthenia Gravis, GeneralizedTaiwan, Germany, Russian Federation, Denmark, Canada
-
BiogenCompletedMultiple SclerosisRussian Federation, Sweden, Germany, Poland, Hungary, United Kingdom, Netherlands, Switzerland, Turkey, Czechia
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
Santen SASCompletedDry Eye Disease With Severe KeratitisCzechia, France, Italy, Poland, Russian Federation, Spain, Turkey
-
AllerganCompletedMultiple Sclerosis | Urinary Incontinence | Neurogenic BladderFrance, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
PfizerTerminatedOsteoarthritisFrance, Germany, Romania, Ukraine, United Kingdom, Spain, Poland, Sweden, Austria, Russian Federation
-
MorphotekCompletedAdenocarcinoma of the LungSpain, United States, Australia, Canada, Germany, Italy, Poland, Russian Federation
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis of the Knee or HipUnited States, Bulgaria, Chile, Colombia, Denmark, Estonia, Germany, Hong Kong, Hungary, Italy, Lithuania, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
Gliknik Inc.CompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Hungary, Ukraine, Russian Federation, Serbia, Poland, Spain
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of...CompletedNon-small Cell Lung CancerPoland, Russian Federation, Bulgaria, United States, Romania, Ukraine
-
SanofiActive, not recruitingMultiple SclerosisBulgaria, Canada, Turkey, Spain, United States, Czechia, France, Germany, Russian Federation, Ukraine
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
AmgenTerminatedAdenocarcinoma of the Pancreas | Locally Advanced | UnresectableSpain, Belgium, Denmark, Poland, United States, Korea, Republic of, Russian Federation, Austria, Portugal, United Kingdom, Germany, Hungary, Czech Republic
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
CEL-SCI CorporationTeva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft PalateSpain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
-
Catalyst Pharmaceuticals, Inc.CompletedA Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)Lambert Eaton Myasthenic SyndromeUnited States, Spain, Serbia, Russian Federation, Hungary, France, Germany, Poland
-
Hoffmann-La RocheWithdrawnMultiple SclerosisSpain, United Kingdom, Czech Republic, Canada, Germany, Slovakia, Poland, Bulgaria, Russian Federation
-
AB ScienceRecruitingProgressive Multiple SclerosisSpain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
-
SanofiActive, not recruitingRelapsing Multiple SclerosisUnited States, Canada, Czechia, Estonia, France, Netherlands, Russian Federation, Spain, Ukraine
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisUnited States, Italy, Russian Federation, Spain
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Austria, Spain, Czechia, Estonia, Bulgaria, Latvia, Lithuania, Russian Federation
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
CelgeneCompletedRelapsing Multiple SclerosisSerbia, United States, Poland, Spain, Belgium, Bulgaria, Georgia, Greece, Romania, Russian Federation, Ukraine, Hungary, Italy
-
ActelionTerminatedPersistent Pulmonary Hypertension of the NewbornUnited States, Australia, Belgium, Czech Republic, France, Germany, Korea, Republic of, Poland, Russian Federation, Singapore, Switzerland, United Kingdom
-
RVL Pharmaceuticals, Inc.Osmotica Pharmaceutical US LLCCompletedMultiple Sclerosis | SpasticityUnited States, Russian Federation, Ukraine
-
SanofiCompletedRelapsing Multiple SclerosisFrance, United States, Canada, Czechia, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Ukraine
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
Genzyme, a Sanofi CompanyActive, not recruitingMultiple SclerosisBelgium, United States, Bulgaria, Canada, China, Estonia, France, Greece, Israel, Lebanon, Lithuania, Morocco, Netherlands, Portugal, Russian Federation, Serbia, Spain, Tunisia, Turkey, Ukraine, United Kingdom
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
EMD SeronoTerminatedRelapsing Multiple SclerosisUnited States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Turkey, Estonia, Germany, Latvia, Poland, Romania, Argentina, Israel, Portugal, Greece, Czech Republic, Slovakia, Serbia, Austria, Finland, Saudi Arabia, Belgium, Canada, Lebanon and more
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
PfizerCompletedOsteoarthritisUnited States, Argentina, Czech Republic, Slovakia, Spain, Belgium, Canada, Peru, Germany, Hungary, Australia, Italy, Poland, Russian Federation
-
BiogenCompletedMultiple SclerosisUnited States, Finland, Italy, United Kingdom, Bulgaria, Serbia, Russian Federation, Lithuania, Poland, Czech Republic, Netherlands
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
TG Therapeutics, Inc.Active, not recruitingRelapsing Multiple Sclerosis (RMS)United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine